During the past decade, Kouvolan lääkäriasema conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Kouvolan lääkäriasema" are "Cystitis, Interstitial" (1 trials), "Hypertension" (1 trials) and "Overactive Bladder" (1 trials). Many other conditions were trialed in "Kouvolan lääkäriasema" in a lesser frequency.

Most popular intervention types in "Kouvolan lääkäriasema" are "Drug" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Amlodipine 10 mg + hydrochlorothiazide 12.5 mg" (1 trials), "Fesoterodine 4mg" (1 trials), "Fesoterodine 8mg" (1 trials) and "Tanezumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kouvolan lääkäriasema" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Kouvolan lääkäriasema". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Kouvolan lääkäriasema, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kouvolan lääkäriasema, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".